97121 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
Sub-classes:METHOD FOR TREATING SEPSIS AND RELATED DISEASES
#2Nasally Administered Formulations for Reducing Allergic Symptoms and Methods of Using the Same
#3METHOD AND COMPOSITION BOTH FOR TREATING OR DIAGNOSING INFLAMMATORY BOWEL DISEASE (IBD)
#4Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
#5ANTIBODY COMPOSITIONS FOR DISRUPTING BIOFILMS
#6CD3-DELTA/EPSILON HETERODIMER SPECIFIC ANTIBODIES
#7TUNABLE POLYMERIC NANOPARTICLES FOR TARGETED AND SUSTAINED DELIVERY OF GLYCOPEPTIDE ANTIBIOTICS
#8IGG1 FC MONOMER AND APPLICATION THEREOF
#9MONOCLONAL ANTIBODY SPECIFIC FOR IR4 OR IR6 PEPTIDES
#10PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#11POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE
#12METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES
#13PROTEIN SCREENING AND DETECTION METHOD
#14ENGINEERED MICROBE-TARGETING MOLECULES AND USES THEREOF
#15Compositions and methods for reducing methane producing bacteria in animals
#16METHODS OF IMMUNOTHERAPY
#17PH LOW INSERTION PEPTIDE AND COMPOSITION THEREOF
#18Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections
#19CD3-DELTA/EPSILON HETERODIMER SPECIFIC ANTIBODIES
#20Peptides and antibodies for the removal of biofilms
#21COMPOSITIONS AND METHODS FOR PREVENTING, INHIBITING, DISRUPTING, OR TREATING A POLYMICROBIAL BIOFILM
#22Covalent Diabodies and Uses Thereof
#23POLY-N-ACETYL GLUCOSAMINE (PNAG/DPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
#24Methods and means for the production of Ig-like molecules
#25PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS
#26MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
#27COMBINATION THERAPIES FOR THE TREATMENT AND PREVENTION OF BIOFILMS
#28Compositions and methods for the removal of biofilms
#29Compositions and Methods to Expedite Antibody-Based Exchange Imaging
#30Methods for purifying antibodies
#31Antibody compositions for disrupting biofilms
#32THERAPEUTIC PROTEIN FORMULATIONS COMPRISING ANTI-DNABII ANTIBODIES AND USES THEREOF
#33Compositions and methods for the removal of biofilms
#34PATHOGEN BINDING METHODS AND COMPOSITIONS
#35GENETICALLY REPROGRAMMED TREGS EXPRESSING CARS
#36Mutant fragments of OspA and methods and uses relating thereto
#37METHODS FOR IDENTIFYING BETA-GLUCAN BINDING TO IMMUNE CELLS
#38METHOD FOR IDENTIFYING HIGH AFFINITY MONOCLONAL ANTIBODY HEAVY AND LIGHT CHAIN PAIRS FROM HIGH THROUGHPUT SCREENS OF B-CELL AND HYBRIDOMA LIBRARIES
#39METHODS OF DETECTING MARKERS FOR INFLAMMATORY CONDITIONS AND FOOD SENSITIVITY IN COMPANION ANIMALS
#40Protein signatures for distinguishing between bacterial and viral infections
#41IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES
#42MANIPULATION OF IMMUNOGLOBULIN GENE DIVERSITY AND MULTI-ANTIBODY THERAPEUTICS
#43POLY-N-ACETYL GLUCOSAMINE (PNAG/DPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
#44Reduction of viral disease transmission by avian antibodies
#45METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS
#46METHODS FOR NONINVASIVE DETECTION, DIAGNOSIS AND TREATMENT OF DISEASE
#47INTEGRATED IMMUNO-PCR AND NUCLEIC ACID ANALYSIS IN AN AUTOMATED REACTION CARTRIDGE
#48Peptides and antibodies for the removal of biofilms
#49PH LOW INSERTION PEPTIDE AND COMPOSITION THEREOF
#50IgG1 FC monomer and application thereof
#51Engineered microbe-targeting molecules and uses thereof
#52Basehit, a high-throughput assay to identify proteins involved in host-microbe interaction
#53Methods and means for the production of Ig-like molecules
#54Proteins and nucleic acids useful in vaccines targeting
#55Antibacterial antibody and use thereof
#56Methods of treating and preventing infections and associated conditions
#57METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION
#58Immunoglobulins and variants directed against pathogenic microbes
#59ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI
#60Engineered microbe-targeting molecules and uses thereof
#61Mutant fragments of OspA and methods and uses relating thereto
#62Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#63SIMULTANEOUS IN VITRO ANALYSIS OF VACCINE POTENCY AND TOXIN CONCENTRATION
#64METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF ANTIBODIES AGAINST INFECTIOUS DISEASES
#65Compositions and methods for reducing methane producing bacteria in animals
#66Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
#67DbpA antibodies and uses thereof
#68Proteins and nucleic acids useful in vaccines targeting
#69Methods and means for the production of ig-like molecules
#70Compositions and methods for the removal of biofilms
#71CHIMERIC ANTIBODIES COMPRISING BINDING DOMAINS OF PHAGE LYSINS, BACTERIAL AUTOLYSINS, BACTERIOCINS, AND PHAGE TAIL OR TAIL FIBERS
#72Targeted enzymatic degradation of quorum-sensing peptides
#73Protein screening and detection method
#74Preparation of bioconjugates and antibodies for the immunodetection of anatoxin-a
#75SYSTEMS AND METHODS FOR ALTERING MICROBIOME TO REDUCE DISEASE RISK AND MANIFESTATIONS OF DISEASE
#76Use of immobilization particles for removal of microorganisms and/or chemicals
#77Antibody to cytolethal distending toxin of Campylobacter jejuni
#78HANP-Fc-containing molecular conjugate
#79DNA Antibody Constructs for Use against Pseudomonas Aeuruginosa
#80Methods for raising antibodies
#81PROTEIN PURIFICATION USING BIS-TRIS BUFFER
#82Methods of treating and preventing infections and associated conditions
#83Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#84Protein signatures for distinguishing between bacterial and viral infections
#85Covalent Diabodies and Uses Thereof
#86Method of treating an eye disorder by inhibiting or disrupting bacterial biofilm formation
#87PATHOGEN BINDING METHODS AND COMPOSITIONS
#88Real-time reporter systems for monitoring base editing
#89Proteins and nucleic acids useful in vaccines targeting
#90Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins
#91Compositions and methods to expedite antibody-based exchange imaging
#92Peptides and antibodies for the removal of biofilms
#93COMPOSITIONS AND METHODS FOR BETA-GLUCAN IMMUNOTHERAPY
#94LIPIDATED STREPTOCOCCUS PNEUMONIAE ANTIGEN COMPOSITIONS, METHODS OF PREPARATION AND USE
#95Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#96Mutant fragments of OspA and methods and uses relating thereto
#97Pathway specific markers for diagnosing irritable bowel syndrome
#98Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#99Detection of serum anti-FadA antibodies and related diagnostic methods
#100INTEGRATED IMMUNO-PCR AND NUCLEIC ACID ANALYSIS IN AN AUTOMATED REACTION CARTRIDGE
#101PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS
#102High affinity antibodies that neutralize enterotoxin B
#103Targeted enzymatic degradation of quorum-sensing peptides
#104Methods of treating and preventing infections and associated conditions
#105Universal antibody-mediated biosensor
#106Methods of identifying bacteria comprising binding polypeptides
#107Methods and means for the production of Ig-like molecules
#108Lipidated antigen compositions, methods of preparation and use
#109Use of a hyperimmune egg product to prevent and treat dysbiosis
#110Engineered microbe-targeting molecules and uses thereof
#111MONOCLONAL ANTIBODY AGAINST MURAMYL PEPTIDES IN PREVENTION AND TREATMENT OF IMMUNE-MEDIATED DISEASES
#112Methods and means for the production of Ig-like molecules
#113Pathway specific markers for diagnosing irritable bowel syndrome
#114Biosensor system for the rapid detection of analytes
#115Biosensor system for the rapid detection of analytes
#116Biosensor system for the rapid detection of analytes
#117Method for purification of monoclonal antibodies
#118Monoclonal antibody against muramyl peptides
#119Mycoplasma pneumoniae detection reagent and application of same
#120Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity
#121Immunoglobulins and variants directed against pathogenic microbes
#122Antibodies that bind thermophilic DNA polymerases
#123Immunoglobulins and variants directed against pathogenic microbes
#124High affinity antibodies that neutralize enterotoxin B
#125Mutant fragments of OspA and methods and uses relating thereto
#126Mutant fragments of OspA and methods and uses relating thereto
#127Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#128Human-derived insect-resistant gene and anti-CRY1B toxin idiotype single-chain antibody encoded thereby and application thereof
#129Compositions and methods relating to Lyme disease
#130Methods of treating and preventing infections and associated conditions
#131Peptide core-based multi-arm linkers for treating central nervous system diseases
#132SpA5 mutant, composition comprising mutant and preparation method and use thereof
#133Biosensor system for the rapid detection of analytes
#134Synthetic antiserum for rapid-turnaround therapies
#135Methods and means for the production of Ig-like molecules
#136Covalent diabodies and uses thereof
#137Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms
#138Pathway specific markers for diagnosing irritable bowel syndrome
#139Use of immobilization particles for removal of microorganisms and/or chemicals
#140Pathway specific assays for predicting irritable bowel syndrome diagnosis
#141Immunoglobulins and variants directed against pathogenic microbes
#142Targeted enzymatic degradation of quorum-sensing peptides
#143Monoclonal antibody against muramyl peptides
#144Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#145QUANTUM DOT-PROTEIN COMPLEXES, FILMS, AND METHODS OF USE
#146Compositions and methods relating to lyme disease
#147Methods of treating and preventing infections and associated conditions
#148Single-domain antibodies with improved thermal stability under cytoplasmic expression
#149Antibody for epitope tagging, hybridoma cell line and uses thereof
#150Peptide tag and uses thereof
#151Immunoglobulins and variants directed against pathogenic microbes
#152Methods for identifying beta-glucan binding to immune cells
#153Compositions and methods for beta-glucan immunotherapy
#154ANTIBODY PRODUCTION METHODS
#155Compositions and methods for the prevention of microbial infections
#156Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome
#157High affinity antibodies that neutralize enterotoxin B
#158Treatment of mucositis with immunoglobulin
#159Treatment and prevention of infections
#160Protein purification using bis-tris buffer
#161Engineered microbe-targeting molecules and uses thereof
#162Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
#163Methods for raising antibodies
#164Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof
#165Methods and means for the production of IG-like molecules
#166Methods and means for the production of Ig-like molecules
#167Methods and means for the production of Ig-like molecules
#168Targeted enzymatic degradation of quorum-sensing peptides
#169Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#170Treating bladder tumor cells using fibronectin attachment protein as a target
#171METHODS AND COMPOSITIONS RELATED TO INTRACELLULAR NEUTRALIZATION BY IgG
#172Methods of treating and preventing infections and associated conditions
#173Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#174Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#175Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#176Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#177High affinity antibodies that neutralize enterotoxin B
#178ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER
#179COMPOSITIONS AND METHODS FOR DEMONSTRATING SECRETORY IMMUNE SYSTEM REGULATION OF STEROID HORMONE RESPONSIVE CANCER CELL GROWTH
#180Immobilization Particles for Removal of Microorganisms and/or Chemicals
#181Protective anti-glucan antibodies with preference for β-1,3-glucans
#182BREAST CANCER ERADICATION PROGRAM
#183Receptor gene screening for detecting or diagnosing cancer
#184Antibody to cytolethal distending toxin of
#185System for selective cell treatment using ideotypically modulated pharmacoeffectors
#186Hybridoma producing antibodies to
#187Hybridoma producing antibodies to
#188Hybridoma producing antibodies to
#189Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#190Hybridoma producing antibodies to
#191Antibodies to
#192Antibodies to
#193Antibodies to
#194Antibodies to
#195DIFFERENTIAL TARGETING OF TRIACYLGLYCEROL SYNTHASE AND WAX SYNTHASE ACTIVITY OF THE TRIACYLGLYCEROL SYNTHASE GENE FOR TUBERCULOSIS TREATMENT
#196CYANOBACTERIA SAXITOXIN GENE CLUSTER AND DETECTION OF CYANOTOXIC ORGANISMS
#197bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel serotype and hybridomas for producing the said antibodies
#198IMMUNOGEN SELECTION DIRECTED IN IMMUNOGLOBULIN PACKAGES IN PLASMA AND COLOSTRUM AND METHOD OF MAKING AND USING SAME
#199SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER
#200Hybridoma producing antibodies to
#201PROPHYLACTIC/THERAPEUTIC AGENT FOR INFECTIOUS DISEASE
#202Treatment and prevention of infections
#203Screening method for predicting susceptibility to breast cancer
#204Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#205Anti-estrogen and immune modulator combinations for treating breast cancer
#206Antibodies specific to antigens of and use of these antigens in immunoassays
#207Protective anti-glucan antibodies with preference for β-1,3-glucans
#208Breast cancer eradication program
#209antigenic polypeptides and compositions
#210Therapeutic agent for ulcerative colitis
#211MILK DERIVED ANTIGEN-SPECIFIC ANTIBODIES, METHODS OF PREPARATION AND USES THEREOF
#212Hybridoma producing antibodies to lawsonia intracellularis
#213METHOD AND AFFINITY COLUMN FOR PURIFYING PROTEINS
#214ANTIGENIC POLYPEPTIDES
#215In SITU Induced Antigen Technology (ISIAT) for Identification of Polynucleotides Expressed during Infection or Colonization
#216Protective anti-glucan antibodies with preference for β-1,3- glucans
#217GROWTH INHIBITORY COMPOSITION AGAINST PATHOGENIC BACTERIA OF MEAT BASED FOOD STUFF COMPRISING IGY
#218Lawsonia intracellularis immunological proteins
#219Use of avian anti-methanogen antibodies for reduction of methane production
#220BREAST CANCER ERADICATION PROGRAM
#221Antibodies specific to antigens of and use of these antigens in immunoassays
#222antigenic composition
#223Method of diagnosing
#224Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
#225Therapeutic agent for ulcerative colitis
#226Antibodies specific to antigens of Bartonella henselae and use of these antigens in immunoassays
#227Covalent diabodies and uses thereof
#228Method of detecting antibodies
#229Cross-beta structures on microbial organisms
#230Broad spectrum pyrogenic antagonists and vaccines directed against pyrogenic exotoxins
#231Preparation method of igy for preventing and cure mouth disease and the toothpaste base on the igy
#232Vaccines for proliferative ileitis and methods of making and using the same
#233Staphylococcus aureus antigenic polypeptides and compositions
#234Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#235In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization
#236Therapeutic agent for ulcerative colitis
#237Antibody against antibacterial peptide and utiliazation thereof
#238Antigenic polypeptides
#239Transgenic plants expressing assembled secretory antibodies
#240Immunogen adherence inhibitor and method of making and using same
#241Heteropolymer complexes and methods for their use
#242Reaction solution for cell-free protein synthesis, method of preparing the same, and protein synthesis method using the same
#243Methods and devices for treating severe peripheral bacterial infections
#244Polypeptides of ()
#245Hybridomas producing highly specific monoclonal antibodies to detect subspecies